335
Views
16
CrossRef citations to date
0
Altmetric
Article

The novel rufigallol-based liquid crystals with cholesterol units: synthesis, mesomorphic and photophysical properties

, , , &
Pages 787-796 | Received 18 Jul 2018, Accepted 26 Sep 2018, Published online: 09 Oct 2018
 

ABSTRACT

Three novel rufigallol derivatives with four alkyl chains and two cholesteric units 6a, 6b and 6c were prepared in yields of 83–88%. The mesomorphic properties were investigated by DSC, POM and XRD analysis, suggesting that compounds 6a, 6b and 6c possess the ordered hexagonal columnar mesophase. The long alkyl chains contribute to the low phase transition temperature. Sample 6c with four dodecyl chains and two cholesterol units is a room temperature liquid crystal between 31°C and 87°C. Compounds 6a, 6b and 6c also have good fluorescence emission between 400 nm and 500 nm. The studies on CD spectra implied that the chiralities of cholesterol moieties are successfully transferred to the liquid crystalline core. Samples 6a, 6b and 6c are the first fluorescence liquid crystal based on rufigallol core with chiral cholesterol units.

GRAPHICAL ABSTRACT

Acknowledgments

This work was financially supported by the National Natural Science Foundation of China (No: 21406036), Fujian Natural Science Foundation of China (No. 2017J01571) and Fuzhou science and technology project (2018-G-44).

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the National Natural Science Foundation of China [21406036].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.